Gregory Fraser
Stock Analyst at Truist Securities
(2.70)
# 1,808
Out of 5,182 analysts
38
Total ratings
55.56%
Success rate
16.78%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $79.47 | +13.25% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $190.94 | +20.46% | 1 | Mar 6, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $5.26 | +33.08% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $0.71 | +22,435.21% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $1.49 | +504.03% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $12.32 | -43.18% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $41.69 | -30.44% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $10.35 | +817.87% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $4.08 | +341.18% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $23.27 | +71.90% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $79.47
Upside: +13.25%
Jazz Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $220 → $230
Current: $190.94
Upside: +20.46%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $5.26
Upside: +33.08%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $0.71
Upside: +22,435.21%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $1.49
Upside: +504.03%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $12.32
Upside: -43.18%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $41.69
Upside: -30.44%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $10.35
Upside: +817.87%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $4.08
Upside: +341.18%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $23.27
Upside: +71.90%